miR-话题@MedSci

#miR#

540篇内容 | 2247人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1930663, encodeId=f89b19306631f, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=J Cell Mol Med：二型糖尿病视网膜病变患者血浆中的miR-29b和miR-200b水平, objectType=article, longId=154915, objectId=c7741549153b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7741549153b, replyNumber=0, likeNumber=64, createdTime=2019-02-21, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7741549153b, moduleTitle=J Cell Mol Med：二型糖尿病视网膜病变患者血浆中的miR-29b和miR-200b水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7741549153b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930699, encodeId=2cd6193069952, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Stem Cells Transl Med：miR-145调节糖尿病 - 骨髓基质细胞诱导的糖尿病脑卒中大鼠神经修复效应, objectType=article, longId=165095, objectId=54a816509541, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54a816509541, replyNumber=0, likeNumber=66, createdTime=2019-06-23, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54a816509541, moduleTitle=Stem Cells Transl Med：miR-145调节糖尿病 - 骨髓基质细胞诱导的糖尿病脑卒中大鼠神经修复效应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54a816509541)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930633, encodeId=2976193063302, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Sci Rep：miR-143和miR-506联合多重活动抑制肺癌细胞周期和体外血管生成, objectType=article, longId=144346, objectId=2256144346ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2256144346ac, replyNumber=0, likeNumber=0, createdTime=2018-09-01, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2256144346ac, moduleTitle=Sci Rep：miR-143和miR-506联合多重活动抑制肺癌细胞周期和体外血管生成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2256144346ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930653, encodeId=8f581930653b9, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=IBD：细胞因子IL-9通过miR21-CLDN8途径触发炎症性肠病的发病机制, objectType=article, longId=150361, objectId=16f4150361a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16f4150361a0, replyNumber=0, likeNumber=58, createdTime=2019-05-14, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16f4150361a0, moduleTitle=IBD：细胞因子IL-9通过miR21-CLDN8途径触发炎症性肠病的发病机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16f4150361a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930665, encodeId=98a4193066547, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=CLIN CANCER RES：循环游离miR-375可以作为Merkel细胞瘤肿瘤负荷标志物, objectType=article, longId=155775, objectId=93ed155e75d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93ed155e75d6, replyNumber=0, likeNumber=63, createdTime=2019-02-23, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93ed155e75d6, moduleTitle=CLIN CANCER RES：循环游离miR-375可以作为Merkel细胞瘤肿瘤负荷标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93ed155e75d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930639, encodeId=1102193063988, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=J Cell Physiol：TNF-α抑制剂诱导的MiR-31减少可激活SATB2/RUNX2通路，促进乙醇诱导的骨坏死的成骨分化, objectType=article, longId=147364, objectId=1a7814e3640a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a7814e3640a, replyNumber=0, likeNumber=0, createdTime=2018-08-29, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a7814e3640a, moduleTitle=J Cell Physiol：TNF-α抑制剂诱导的MiR-31减少可激活SATB2/RUNX2通路，促进乙醇诱导的骨坏死的成骨分化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a7814e3640a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930625, encodeId=cc1d193062567, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=J Rheumatol：miR-98在系统性红斑狼疮中的作用及其潜在机制, objectType=article, longId=141229, objectId=40ed1412290c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40ed1412290c, replyNumber=0, likeNumber=67, createdTime=2018-11-20, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40ed1412290c, moduleTitle=J Rheumatol：miR-98在系统性红斑狼疮中的作用及其潜在机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40ed1412290c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930673, encodeId=441f19306e3b4, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Inflam Bowel Dis：miR-206可以作为溃疡性结肠炎对美沙拉嗪治疗反应的生物标志物, objectType=article, longId=157175, objectId=d85415e175ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d85415e175ac, replyNumber=0, likeNumber=153, createdTime=2019-03-10, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d85415e175ac, moduleTitle=Inflam Bowel Dis：miR-206可以作为溃疡性结肠炎对美沙拉嗪治疗反应的生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d85415e175ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930689, encodeId=b025193068955, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=ImmunoGen的抗体 - 药物偶联物Mirvetuximab soravtansine未达到III期卵巢癌研究的主要终点, objectType=article, longId=161544, objectId=4fbf1615443f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4fbf1615443f, replyNumber=0, likeNumber=56, createdTime=2019-08-17, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4fbf1615443f, moduleTitle=ImmunoGen的抗体 - 药物偶联物Mirvetuximab soravtansine未达到III期卵巢癌研究的主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4fbf1615443f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930621, encodeId=4c8c1930621ec, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Gastroenterology：MiRNA检测在巴雷特食管诊断中的应用, objectType=article, longId=140685, objectId=7b49140685f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b49140685f8, replyNumber=0, likeNumber=128, createdTime=2018-09-26, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b49140685f8, moduleTitle=Gastroenterology：MiRNA检测在巴雷特食管诊断中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b49140685f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930623, encodeId=70bd193062320, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=J Cell Sci：研究揭示miR-200b在血管发生和成骨之间作用的机制, objectType=article, longId=141011, objectId=cc2a14101131, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc2a14101131, replyNumber=0, likeNumber=49, createdTime=2018-11-02, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc2a14101131, moduleTitle=J Cell Sci：研究揭示miR-200b在血管发生和成骨之间作用的机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc2a14101131)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930651, encodeId=934919306510c, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=BJC：BM-MSCs来源的外泌体通过miR-142-3p增加肿瘤干细胞数量, objectType=article, longId=150144, objectId=cd5215014494, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd5215014494, replyNumber=0, likeNumber=79, createdTime=2019-07-04, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd5215014494, moduleTitle=BJC：BM-MSCs来源的外泌体通过miR-142-3p增加肿瘤干细胞数量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd5215014494)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930657, encodeId=4587193065e25, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=【盘点】：miRNA 在眼科中研究进展, objectType=article, longId=151575, objectId=c4191515e596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4191515e596, replyNumber=0, likeNumber=60, createdTime=2019-01-15, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4191515e596, moduleTitle=【盘点】：miRNA 在眼科中研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4191515e596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930695, encodeId=d966193069568, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Cancer Biomark：Circ0001429通过结合miR-205-5p和促进VEGFA表达来调节膀胱癌的进展, objectType=article, longId=163075, objectId=08cd1630e5c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=08cd1630e5c1, replyNumber=0, likeNumber=60, createdTime=2019-11-10, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=08cd1630e5c1, moduleTitle=Cancer Biomark：Circ0001429通过结合miR-205-5p和促进VEGFA表达来调节膀胱癌的进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=08cd1630e5c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930681, encodeId=33431930681dd, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Alexion的Ultomiris达到了非典型溶血性尿毒症综合征晚期研究的主要目标, objectType=article, longId=159162, objectId=d59815916279, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d59815916279, replyNumber=0, likeNumber=59, createdTime=2019-02-14, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d59815916279, moduleTitle=Alexion的Ultomiris达到了非典型溶血性尿毒症综合征晚期研究的主要目标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d59815916279)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930697, encodeId=57a5193069e3e, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Mirada Medical投入600万英镑开发基于人工智能的成像软件，助力肿瘤放射治疗, objectType=article, longId=163901, objectId=1e13163901a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e13163901a1, replyNumber=0, likeNumber=52, createdTime=2019-09-08, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e13163901a1, moduleTitle=Mirada Medical投入600万英镑开发基于人工智能的成像软件，助力肿瘤放射治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e13163901a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930685, encodeId=9a1a1930685cf, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Eur Rev Med Pharmacol Sci：MiR-146a调节创伤性股骨头坏死中骨髓基质细胞的成骨分化和增殖, objectType=article, longId=159565, objectId=7c6a15956560, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c6a15956560, replyNumber=0, likeNumber=74, createdTime=2019-05-22, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c6a15956560, moduleTitle=Eur Rev Med Pharmacol Sci：MiR-146a调节创伤性股骨头坏死中骨髓基质细胞的成骨分化和增殖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c6a15956560)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930645, encodeId=2324193064594, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Stem Cell Res Ther：miR-431通过靶向胰岛素受体物质2抑制人骨髓间充质干细胞的脂肪形成分化, objectType=article, longId=148401, objectId=deb114840170, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=deb114840170, replyNumber=0, likeNumber=0, createdTime=2019-06-04, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=deb114840170, moduleTitle=Stem Cell Res Ther：miR-431通过靶向胰岛素受体物质2抑制人骨髓间充质干细胞的脂肪形成分化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=deb114840170)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930612, encodeId=a32619306122e, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Stem Cells Dev：miR-450b通过靶向BMP3促进体外成骨分化并增强体内骨形成, objectType=article, longId=135367, objectId=91c813536efe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91c813536efe, replyNumber=0, likeNumber=55, createdTime=2018-10-05, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91c813536efe, moduleTitle=Stem Cells Dev：miR-450b通过靶向BMP3促进体外成骨分化并增强体内骨形成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91c813536efe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930677, encodeId=fa7219306e727, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=CLIN CANCER RES：miR-31-3p表达可以预测西妥昔单抗疗效, objectType=article, longId=158586, objectId=7cca15858623, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cca15858623, replyNumber=0, likeNumber=68, createdTime=2019-01-27, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cca15858623, moduleTitle=CLIN CANCER RES：miR-31-3p表达可以预测西妥昔单抗疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cca15858623)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

miR

2020-05-29

smallant2002 (审核中...)

前往app查看评论内容

#miR#

J Cell Mol Med：二型糖尿病视网膜病变患者血浆中的miR-29b和miR-200b水平

2019-02-21

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Stem Cells Transl Med：miR-145调节糖尿病 - 骨髓基质细胞诱导的糖尿病脑卒中大鼠神经修复效应

2019-06-23

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Sci Rep：miR-143和miR-506联合多重活动抑制肺癌细胞周期和体外血管生成

2018-09-01

smallant2002 (审核中...)

前往app查看评论内容

#miR#

IBD：细胞因子IL-9通过miR21-CLDN8途径触发炎症性肠病的发病机制

2019-05-14

smallant2002 (审核中...)

前往app查看评论内容

#miR#

CLIN CANCER RES：循环游离miR-375可以作为Merkel细胞瘤肿瘤负荷标志物

2019-02-23

smallant2002 (审核中...)

前往app查看评论内容

#miR#

J Cell Physiol：TNF-α抑制剂诱导的MiR-31减少可激活SATB2/RUNX2通路，促进乙醇诱导的骨坏死的成骨分化

2018-08-29

smallant2002 (审核中...)

前往app查看评论内容

#miR#

J Rheumatol：miR-98在系统性红斑狼疮中的作用及其潜在机制

2018-11-20

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Inflam Bowel Dis：miR-206可以作为溃疡性结肠炎对美沙拉嗪治疗反应的生物标志物

2019-03-10

smallant2002 (审核中...)

前往app查看评论内容

#miR#

ImmunoGen的抗体 - 药物偶联物Mirvetuximab soravtansine未达到III期卵巢癌研究的主要终点

2019-08-17

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Gastroenterology：MiRNA检测在巴雷特食管诊断中的应用

2018-09-26

smallant2002 (审核中...)

前往app查看评论内容

#miR#

J Cell Sci：研究揭示miR-200b在血管发生和成骨之间作用的机制

2018-11-02

smallant2002 (审核中...)

前往app查看评论内容

#miR#

BJC：BM-MSCs来源的外泌体通过miR-142-3p增加肿瘤干细胞数量

2019-07-04

smallant2002 (审核中...)

前往app查看评论内容

#miR#

【盘点】：miRNA 在眼科中研究进展

2019-01-15

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Cancer Biomark：Circ0001429通过结合miR-205-5p和促进VEGFA表达来调节膀胱癌的进展

2019-11-10

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Alexion的Ultomiris达到了非典型溶血性尿毒症综合征晚期研究的主要目标

2019-02-14

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Mirada Medical投入600万英镑开发基于人工智能的成像软件，助力肿瘤放射治疗

2019-09-08

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Eur Rev Med Pharmacol Sci：MiR-146a调节创伤性股骨头坏死中骨髓基质细胞的成骨分化和增殖

2019-05-22

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Stem Cell Res Ther：miR-431通过靶向胰岛素受体物质2抑制人骨髓间充质干细胞的脂肪形成分化

2019-06-04

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Stem Cells Dev：miR-450b通过靶向BMP3促进体外成骨分化并增强体内骨形成

2018-10-05

smallant2002 (审核中...)

前往app查看评论内容

#miR#

CLIN CANCER RES：miR-31-3p表达可以预测西妥昔单抗疗效

2019-01-27

科室
- - 订阅+
  - 更多科室
工具
服务